INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 430m ago
House PTR30m ago
SEC 13F29m ago
Robinhood Chain29m ago

Results

80,116 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
SC
Shultz Ronald CraigGM, ACI Speedpay
ACIWACI WORLDWIDE, INC.
Disposition to issuer
D$16K
370 sh
Mar 4, 2026Mar 6, 2026
Page 1419 of 2003
← PrevNext →
traded Mar 4, 2026
+2d
SEC Form 4

Evidence

8
MA
Mitchell AndreaDirector
DAVEDave Inc./DE
Open-market sale · 10b5-1 plan
SELL$64K
300 sh
Mar 5, 2026Mar 6, 2026
traded Mar 5, 2026
+1dSEC Form 4

Evidence

8
MA
Mitchell AndreaDirector
DAVEDave Inc./DE
Open-market sale · 10b5-1 plan
SELL$110K
500 sh
Mar 5, 2026Mar 6, 2026
traded Mar 5, 2026
+1dSEC Form 4

Evidence

8
SS
Slocum Jeffrey ShannonDirector, Director, EVP and COO
HALHALLIBURTON CO
Tax withholding
F$123K
3,404 sh
Mar 5, 2026Mar 6, 2026
traded Mar 5, 2026
+1dSEC Form 4

Evidence

8
MA
Mitchell AndreaDirector
DAVEDave Inc./DE
Open-market sale · 10b5-1 plan
SELL$73K
350 sh
Mar 5, 2026Mar 6, 2026
traded Mar 5, 2026
+1dSEC Form 4

Evidence

8
MA
Mitchell AndreaDirector
DAVEDave Inc./DE
Open-market sale · 10b5-1 plan
SELL$395K
1,871 sh
Mar 6, 2026Mar 6, 2026
traded Mar 6, 2026
+0dSEC Form 4

Evidence

8
MA
Mitchell AndreaDirector
DAVEDave Inc./DE
Open-market sale · 10b5-1 plan
SELL$293K
1,412 sh
Mar 6, 2026Mar 6, 2026
traded Mar 6, 2026
+0dSEC Form 4

Evidence

8
MA
Mitchell AndreaDirector
DAVEDave Inc./DE
Open-market sale · 10b5-1 plan
SELL$428K
2,004 sh
Mar 6, 2026Mar 6, 2026
traded Mar 6, 2026
+0dSEC Form 4

Evidence

8
MA
Mitchell AndreaDirector
DAVEDave Inc./DE
Open-market sale · 10b5-1 plan
SELL$126K
570 sh
Mar 5, 2026Mar 6, 2026
traded Mar 5, 2026
+1dSEC Form 4

Evidence

8
MA
Mitchell AndreaDirector
DAVEDave Inc./DE
Open-market sale · 10b5-1 plan
SELL$346K
1,645 sh
Mar 6, 2026Mar 6, 2026
traded Mar 6, 2026
+0dSEC Form 4

Evidence

8
MB
Mookerji Suman B.Sr. V.P., C.F.O.
DCODUCOMMUN INC /DE/
Tax withholding
F$177K
1,361 sh
Mar 5, 2026Mar 6, 2026
traded Mar 5, 2026
+1dSEC Form 4

Evidence

8
MA
Mitchell AndreaDirector
DAVEDave Inc./DE
Open-market sale · 10b5-1 plan
SELL$67K
300 sh
Mar 5, 2026Mar 6, 2026
traded Mar 5, 2026
+1dSEC Form 4

Evidence

8
MA
Mitchell AndreaDirector
DAVEDave Inc./DE
Open-market sale · 10b5-1 plan
SELL$452K
2,158 sh
Mar 6, 2026Mar 6, 2026
traded Mar 6, 2026
+0dSEC Form 4

Evidence

8
MA
Mitchell AndreaDirector
DAVEDave Inc./DE
Open-market sale · 10b5-1 plan
SELL$151K
700 sh
Mar 5, 2026Mar 6, 2026
traded Mar 5, 2026
+1dSEC Form 4

Evidence

8
MA
Mitchell AndreaDirector
DAVEDave Inc./DE
Open-market sale · 10b5-1 plan
SELL$130K
600 sh
Mar 5, 2026Mar 6, 2026
traded Mar 5, 2026
+1dSEC Form 4

Evidence

8
MA
Mitchell AndreaDirector
DAVEDave Inc./DE
Open-market sale · 10b5-1 plan
SELL$175K
800 sh
Mar 5, 2026Mar 6, 2026
traded Mar 5, 2026
+1dSEC Form 4

Evidence

8
MA
Mitchell AndreaDirector
DAVEDave Inc./DE
Open-market sale · 10b5-1 plan
SELL$371K
1,782 sh
Mar 6, 2026Mar 6, 2026
traded Mar 6, 2026
+0dSEC Form 4

Evidence

6
SI
Stefan Constantin IonelChief Technology Officer
AMPXAmprius Technologies, Inc.
Grant or award
A—
110.0K sh
Mar 4, 2026Mar 6, 2026
traded Mar 4, 2026
+2dSEC Form 4

Evidence

5
MA
Mitchell AndreaDirector
DAVEDave Inc./DE
Open-market sale · 10b5-1 plan
SELL$194K
900 sh
Mar 6, 2026Mar 6, 2026
traded Mar 6, 2026
+0dSEC Form 4

Evidence

5
MA
Mitchell AndreaDirector
DAVEDave Inc./DE
Open-market sale · 10b5-1 plan
SELL$45K
200 sh
Mar 5, 2026Mar 6, 2026
traded Mar 5, 2026
+1dSEC Form 4

Evidence

5
SE
Storey Lisa EChief Legal Officer
EVCMEverCommerce Inc.
Tax withholding
F$19K
1,577 sh
Mar 5, 2026Mar 6, 2026
traded Mar 5, 2026
+1dSEC Form 4

Evidence

5
MA
Mitchell AndreaDirector
DAVEDave Inc./DE
Open-market sale · 10b5-1 plan
SELL$156K
722 sh
Mar 6, 2026Mar 6, 2026
traded Mar 6, 2026
+0dSEC Form 4

Evidence

5
MA
Mitchell AndreaDirector
DAVEDave Inc./DE
Open-market sale · 10b5-1 plan
SELL$216K
1,007 sh
Mar 6, 2026Mar 6, 2026
traded Mar 6, 2026
+0dSEC Form 4

Evidence

5
RR
Remer Eric RichardDirector, Chief Executive Officer
EVCMEverCommerce Inc.
Tax withholding
F$145K
12.0K sh
Mar 5, 2026Mar 6, 2026
traded Mar 5, 2026
+1dSEC Form 4

Evidence

5
JR
Jain RachitEVP & CFO
SDGRSchrodinger, Inc.
Open-market sale · 10b5-1 plan
SELL$21K
1,631 sh
Mar 5, 2026Mar 6, 2026
traded Mar 5, 2026
+1dSEC Form 4

Evidence

5
MG
Martell Jorge GarciaChief Financial Officer
OSPNOneSpan Inc.
Option exercise
M—
3,055 sh
Mar 6, 2026Mar 6, 2026
traded Mar 6, 2026
+0dSEC Form 4

Evidence

5
FA
Flees Lori AnnDirector, President & CEO
VVVVALVOLINE INC
Grant or award
A$974
27 sh
Mar 5, 2026Mar 6, 2026
traded Mar 5, 2026
+1dSEC Form 4

Evidence

5
MG
Martell Jorge GarciaChief Financial Officer
OSPNOneSpan Inc.
Tax withholding
F$9,681
889 sh
Mar 6, 2026Mar 6, 2026
traded Mar 6, 2026
+0dSEC Form 4

Evidence

5
MG
Martell Jorge GarciaChief Financial Officer
OSPNOneSpan Inc.
Option exercise
M—
3,055 sh
Mar 6, 2026Mar 6, 2026
traded Mar 6, 2026
+0dSEC Form 4

Evidence

5
AJ
Aguila JavierSee Remarks
HHyatt Hotels Corp
Tax withholding
F$39K
239 sh
Mar 4, 2026Mar 6, 2026
traded Mar 4, 2026
+2dSEC Form 4

Evidence

5
BE
Bertels Mark E.EVP - Risk Management Services
CRVLCORVEL CORP
Grant or award
A—
6,000 sh
Mar 4, 2026Mar 6, 2026
traded Mar 4, 2026
+2dSEC Form 4

Evidence

3
RA
Reardon AndrewCLO & Secretary
LGNDLIGAND PHARMACEUTICALS INC
Option exercise · 10b5-1 plan
M—
5,000 sh
Mar 4, 2026Mar 6, 2026
traded Mar 4, 2026
+2dSEC Form 4

Evidence

3
FJ
Fitzpatrick JenniferChief Legal Officer
SIONSionna Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
10.3K sh
Mar 5, 2026Mar 6, 2026
traded Mar 5, 2026
+1dSEC Form 4

Evidence

1
FD
Feierstein Matthew DavidPresident
EVCMEverCommerce Inc.
Open-market sale · 10b5-1 plan
SELL$120K
10.0K sh
Mar 4, 2026Mar 6, 2026
traded Mar 4, 2026
+2dSEC Form 4

Evidence

1
MA
Mitchell AndreaDirector
DAVEDave Inc./DE
Open-market sale · 10b5-1 plan
SELL$166K
803 sh
Mar 6, 2026Mar 6, 2026
traded Mar 6, 2026
+0dSEC Form 4

Evidence

1
MA
Mitchell AndreaDirector
DAVEDave Inc./DE
Open-market sale · 10b5-1 plan
SELL$105K
496 sh
Mar 6, 2026Mar 6, 2026
traded Mar 6, 2026
+0dSEC Form 4

Evidence

1
FD
Feierstein Matthew DavidPresident
EVCMEverCommerce Inc.
Open-market sale · 10b5-1 plan
SELL$61K
5,000 sh
Mar 5, 2026Mar 6, 2026
traded Mar 5, 2026
+1dSEC Form 4

Evidence

0
FJ
Fitzpatrick JenniferChief Legal Officer
SIONSionna Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$63K
10.3K sh
Mar 5, 2026Mar 6, 2026
traded Mar 5, 2026
+1dSEC Form 4

Evidence

0
EO
Espinoza OctavioChief Financial Officer
LGNDLIGAND PHARMACEUTICALS INC
Option exercise · 10b5-1 plan
M$38K
466 sh
Mar 4, 2026Mar 6, 2026
traded Mar 4, 2026
+2dSEC Form 4

Evidence

0
EO
Espinoza OctavioChief Financial Officer
LGNDLIGAND PHARMACEUTICALS INC
Option exercise · 10b5-1 plan
M—
1,607 sh
Mar 4, 2026Mar 6, 2026
traded Mar 4, 2026
+2dSEC Form 4

Evidence